Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

What Is Moving Tenon Medical (NASDAQ:TNON) on Thin Volume?

Tenon Medical (NASDAQ:TNON) makes the Catamaran sacroiliac joint fusion system, a medical device used in procedures on the joint that links the spine and pelvis. The shares slipped 0.87% in the October 9, 2026 session, and the more notable fact is how little traded. …

Vinay Lochav | 12 October 2026

How Did Intellia (NASDAQ:NTLA) Trade 3.4 Times Its Average Volume?

Intellia Therapeutics (NASDAQ:NTLA) traded 13.954M shares in the October 9, 2026 session, roughly 3.4 times its three-month average, yet the price rose only 3.73%. That mismatch is the main feature of the day. High volume with a small move can mean large buyers and …

Vinay Lochav | 12 October 2026

Why Did C4 Therapeutics (NASDAQ:CCCC) Gain 10.88% to USD 3.16?

C4 Therapeutics (NASDAQ:CCCC) rose 10.88% in the October 9, 2026 session, the largest gain among the seven names in this group of articles. Trading was only about 1.2 times its three-month average, which suggests the move did not draw a crowd of new participants. …

Vinay Lochav | 12 October 2026

Why Did Novavax (NASDAQ:NVAX) Surge 15.8% in One Session?

Novavax (NASDAQ:NVAX), a protein-based vaccine maker with a Sanofi partnership, rose USD 1.74 to USD 12.75 in the October 9, 2026 session. Working back from the published change, the prior close was about USD 11.01. Volume of 6.199M shares was about 1.2 times the …

Vinay Lochav | 12 October 2026

Is Picard Medical (NYSEAMERICAN:PMI) stock overbought after falling 6.65 percent following a post-earnings surge?

Picard Medical's 6.65 percent pre-market decline to 9.48 dollars arrives with a 14-day RSI of 70.5, a reading in overbought territory that typically follows a period of strong recent buying rather than signaling a new downtrend on its own. That context fits the stock's …

Vinay Lochav | 12 October 2026

Baxter International Inc. (NYSE:BAX) Price Target: Why Do Data Sets Disagree So Sharply?

● BAX closed at $24.33 on 9 October 2026, with two data sets disagreeing sharply on the average analyst target, at $21.73 and $28.73.

Nitish Kishor | 12 October 2026

This NYSE Medical Technology Stock Trades Barely Below Its Analyst Consensus

● BDX closed at $183.69 on 9 October 2026, and the $185.07 consensus target implies upside of only about 0.8%.

Nitish Kishor | 12 October 2026

What Is the Price Target for Agilent Technologies, Inc. (NYSE:A) in the S&P 500?

● Agilent shares closed at $170.75 on 9 October 2026, and the second data set's $175.20 mean target implies upside of about 2.6%.

Nitish Kishor | 12 October 2026

AbbVie Inc. (NYSE:ABBV) Price Target: Brokers Raise Forecasts as Shares Sit Near the Consensus

● ABBV closed at $276.24 on 9 October 2026, with the second data set's $282.61 average target implying about 2.3% upside.

Nitish Kishor | 12 October 2026

Abbott Laboratories (NYSE:ABT) Price Target: Where Do Analysts See the S&P 500 Stock Heading?

● ABT closed at $99.71 on 9 October 2026, and the $118.88 consensus target implies upside of roughly 19.2%.

Nitish Kishor | 12 October 2026
Support

Hi! How can we help you today?

Loading…